A population-based study of plasma cyclic guanosine monophosphate:: relations to age, atrial natriuretic factor and angiotensin-converting enzyme activity

被引:1
|
作者
Nyström, FH
Ahlner, J
Karlberg, BE
Öhman, PK [1 ]
机构
[1] Linkoping Univ Hosp, Fac Hlth Sci, Dept Med & Care, S-58185 Linkoping, Sweden
[2] Linkoping Univ Hosp, Fac Hlth Sci, Dept Clin Pharmacol, S-58185 Linkoping, Sweden
关键词
blood pressure monitoring; cyclic guanosine monophosphate; atrial natriuretic factor; angiotensin-converting enzyme;
D O I
10.1080/00365519850186021
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In order to study the relations between plasma cyclic guanosine monophosphate (cGMP) and anthropometric variables, plasma atrial natriuretic factor (ANP) and serum angiotensin-converting enzyme activity (ACE), a population study with random selection of 217 subjects (49% men) 18-69 years old was performed. Venous blood was drawn at 08.00 h and ambulatory blood pressure (ABP) recording was then performed. There was no gender-difference in cGMP levels (men 2.2 +/- 1.1 nmol L-1 women 2.2 +/- 1.1 nmol L-1). A weak negative correlation was seen between cGMP and systolic ABP in both genders 20-44 years of age (r= -0.3, p=0.05 for both), but this correlation did not persist in multivariate analysis with correction for ANP, age and ACE. In women, cGMP correlated positively with ANP (r = 0.27, p = 0.005) independently of ANP, ACE, ABP and age. ACE correlated negatively with cGMP in men (all; r = -0.22, p = 0.03, 45 - 69 years of age r= -0.49, p = 0.0002) and this correlation was independent of ANP, ACE, ABP and age. ACE catalyses the breakdown of bradykinin, which stimulates the release of NO. As the second messenger of NO is cGMP, the negative correlation between ACE and cGMP in men might be a reflection of reduced production of NO. Our results also suggest that there are gender differences in the stimuli for basal cGMP production.
引用
收藏
页码:605 / 610
页数:6
相关论文
共 50 条
  • [1] Diagnostic Utility of Angiotensin-Converting Enzyme in Sarcoidosis: A Population-Based Study
    Patompong Ungprasert
    Eva M. Carmona
    Cynthia S. Crowson
    Eric L. Matteson
    Lung, 2016, 194 : 91 - 95
  • [2] Diagnostic Utility of Angiotensin-Converting Enzyme in Sarcoidosis: A Population-Based Study
    Ungprasert, Patompong
    Carmona, Eva M.
    Crowson, Cynthia S.
    Matteson, Eric L.
    LUNG, 2016, 194 (01) : 91 - 95
  • [3] Angiotensin-Converting Enzyme Inhibitors and Active Tuberculosis: A Population-Based Study
    Wu, Jiunn-Yih
    Lee, Meng-Tse Gabriel
    Lee, Si-Huei
    Lee, Shih-Hao
    Tsai, Yi-Wen
    Hsu, Shou-Chien
    Chang, Shy-Shin
    Lee, Chien-Chang
    MEDICINE, 2016, 95 (19)
  • [4] ATRIAL-NATRIURETIC-FACTOR INHIBITS ANGIOTENSIN CONVERTING ENZYME-ACTIVITY
    SAWA, H
    KAWAGUCHI, H
    CIRCULATION, 1990, 82 (04) : 682 - 682
  • [5] Serum angiotensin-converting enzyme and plasma atrial natriuretic peptide levels in hyperthyroid and hypothyroid rabbits
    Yegin, E
    Yigitoglu, MR
    Ari, Z
    Celik, I
    Akcay, F
    Suzek, H
    JAPANESE HEART JOURNAL, 1997, 38 (02): : 273 - 279
  • [6] Serum angiotensin-converting enzyme activity correlates positively with plasma angiotensin II: A population-based study of ambulatory blood pressure and the renin-angiotensin system
    Nystrom, F
    Karlberg, BE
    Ohman, KP
    JOURNAL OF HUMAN HYPERTENSION, 1997, 11 (05) : 301 - 306
  • [7] Serum angiotensin-converting enzyme activity correlates positively with plasma angiotensin II: a population-based study of ambulatory blood pressure and the renin-angiotensin system
    F Nyström
    BE Karlberg
    KP Öhman
    Journal of Human Hypertension, 1997, 11 : 301 - 306
  • [8] Study of the use of a spironolactone and angiotensin-converting enzyme inhibitor combination:: a population-based analysis
    Besancon, Jean-Francois
    Lagarce, Laurence
    Diquet, Bertrand
    Laine-Cessac, Pascale
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (02) : 172 - 179
  • [9] Angiotensin-converting enzyme inhibitors and the risk of cancer -: A population-based cohort study in Denmark
    Friis, S
    Sorensen, HT
    Mellemkjær, L
    McLaughlin, JK
    Nielsen, GL
    Blot, WJ
    Olsen, JH
    CANCER, 2001, 92 (09) : 2462 - 2470
  • [10] Angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers and hemorrhoids: A nationwide, population-based study
    Hu, Wei-Syun
    Lin, Cheng-Li
    MEDICINE, 2023, 102 (22) : E33875